Randall S Stafford1, Todd H Wagner, Philip W Lavori. Show Affiliations » 1. Stanford Prevention Research Center, Stanford University, Palo Alto, California, USA.
Abstract
Mesh: See more » Cost-Benefit AnalysisDrug Labeling/legislation & jurisprudenceDrug Labeling/trendsGovernment RegulationHealth Services ResearchHumansTherapeutic EquivalencyTreatment OutcomeUnited StatesUnited States Food and Drug Administration
Year: 2009 PMID: 19675326 DOI: 10.1056/NEJMp0906490
Source DB: PubMed Journal: N Engl J Med ISSN: 0028-4793 Impact factor: 91.245